28 Feb 2018 12:36
NMC Health plc to Report Full Year 2017 Results on 7 March 2018
London, 28 February 2018: NMC Health plc (the "Company") will report its full year 2017 financial results (for the twelve months to 31 December 2017) on Wednesday, 7 March 2018.
The results are expected to be published on the Regulatory News Service at 7am UK time on that day, and shortly thereafter on the Company's website at http://www.nmchealth.com/investor-relations/.
Contacts
NMC |
|
Prasanth Manghat, Deputy Chief Executive Officer Prashanth Shenoy, Chief Financial Officer Asjad Yahya, Investor Relations | +971 (0)50 522 5648 +971 (0)56 329 0545 +971 (0)56 219 0975 |
Media | |
FTI Consulting, London | |
Brett Pollard / Mo Noonan / Victoria Foster-Mitchell | +44 (0)20 3727 1000 |
FTI Consulting, Gulf | |
Shane Dolan | +971 (0)4 437 2100 |
About NMC Health
The NMC group (the "Group") is the leading United Arab Emirates private healthcare operator with an international network of hospitals. The Group currently operates or manages over 130 assets across 13 countries. NMC is also ranked as one of the top 3 in-vitro fertilisation ("IVF") operators globally. The Group is also a leading provider of long-term medical care in the UAE through its subsidiary ProVita. Pursing an aggressive international expansion program from 2016, the company now has over 35% of its licensed bed capacity in the Kingdom of Saudi Arabia (KSA), where the company has introduced long-term and multi-specialty care services. The enlarged Group received almost 4.3 million patients in 2016. The Group is also a leading UAE supplier of products and consumables across several key market segments, with the major contribution coming from healthcare related products. The Group reported revenues of US$1.2 billion for the year ended 31 December 2016.
In April 2012 NMC was listed on the Premium Segment of the London Stock Exchange. NMC is a constituent of the FTSE 100 Index.